INVO Bioscience, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
INVO Bioscience, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • INVO Bioscience, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 3.86M shares, a 367% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.86M +3.04M +367% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 2.62M -11.4M -81.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 2.49M +1.88M +310% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 2.47M -9.69M -79.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 827K -11.3M -93.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 14M +1.87M +15.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 609K -11.3M -94.9% Dec 31, 2022 10-K/A 2024-04-17
Q3 2022 12.2M +1.7M +16.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 12.1M +1.67M +16% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 12.1M +1.67M +16% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 11.9M +2.29M +23.8% Dec 31, 2021 10-K 2023-04-17
Q3 2021 10.5M +5.51M +111% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 10.5M +2.56M +32.4% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 10.4M -147M -93.4% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 9.64M +4.75M +97.3% Dec 31, 2020 10-K 2022-03-31
Q3 2020 4.95M -151M -96.8% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 7.9M -148M -94.9% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 158M +3.15M +2.04% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 4.88M -149M -96.8% Dec 31, 2019 10-K 2021-03-30
Q3 2019 156M +8.14M +5.52% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 156M +8.09M +5.49% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 155M +10.6M +7.38% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 154M +12.2M +8.56% Dec 31, 2018 10-K 2020-03-30
Q3 2018 147M +5.77M +4.08% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 147M +6.17M +4.37% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 144M +2.86M +2.03% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 142M +1.54M +1.09% Dec 31, 2017 10-K 2019-04-16
Q3 2017 142M +1.08M +0.77% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 141M +688K +0.49% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 141M +4.05M +2.95% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 141M +3.51M +2.56% Dec 31, 2016 10-K 2018-03-29
Q3 2016 141M +6.52M +4.86% Sep 30, 2016 10-Q 2017-09-05
Q2 2016 141M +7.52M +5.65% Jun 30, 2016 10-Q 2017-09-05
Q1 2016 137M +17.2M +14.4% Mar 31, 2016 10-Q 2017-09-05
Q4 2015 137M +17.4M +14.5% Dec 31, 2015 10-Q 2017-09-05
Q3 2015 134M +22.7M +20.4% Sep 30, 2015 10-K 2017-03-17
Q2 2015 133M +21.7M +19.5% Jun 30, 2015 10-K 2017-03-17
Q1 2015 120M +8.46M +7.59% Mar 31, 2015 10-K 2017-03-17
Q4 2014 120M +8.33M +7.48% Dec 31, 2014 10-K 2017-03-17
Q3 2014 111M +1.25M +1.14% Sep 30, 2014 10-K 2017-03-17
Q2 2014 111M +3M +2.77% Jun 30, 2014 10-K 2017-03-17
Q1 2014 111M +5.61M +5.3% Mar 31, 2014 10-K 2017-03-17
Q4 2013 111M +17.9M +19.1% Dec 31, 2013 10-K 2017-03-17
Q3 2013 110M +18.8M +20.6% Sep 30, 2013 10-K 2017-03-17
Q2 2013 108M +17.3M +19% Jun 30, 2013 10-K 2017-03-17
Q1 2013 106M +19M +21.9% Mar 31, 2013 10-K 2017-03-17
Q4 2012 93.5M +10.4M +12.5% Dec 31, 2012 10-K 2017-03-17
Q3 2012 91.4M +11.3M +14.1% Sep 30, 2012 10-K 2017-03-17
Q2 2012 91.1M +13.2M +16.9% Jun 30, 2012 10-K 2017-03-17
Q1 2012 86.8M Mar 31, 2012 10-K 2017-03-17
Q4 2011 83.1M +8.54M +11.5% Dec 31, 2011 10-K 2017-03-17
Q3 2011 80M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 77.9M Jun 30, 2011 10-Q 2011-08-22
Q4 2010 74.5M Dec 31, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.